CGS-authored

A 21st-century gold rush is on in California after the voters approved $3 billion for human embryonic stem cell research.

At least one out-of-state biotech company is already making plans to move to California. Stem cell start-up businesses are expected to emerge. And universities are hoping to recruit some of the field's brightest minds to take part in the biggest state-run research project in U.S. history.

The voters' 59 percent approval of the bond measure on Election Day represents a resounding rejection of Bush administration policy, which has sharply restricted federal funding for research that involves the destruction of human embryos.

Stem cells can potentially grow into any type of human tissue. Many scientists believe stem cells could someday be used to repair crippling spinal cord injuries and treat an array of diseases, including diabetes and Parkinson's.

Proponents and critics alike expect the new agency created under the ballot measure, the California Institute for Regenerative Medicine, to serve as a state version of the National Institutes of Health.

But myriad questions remain to be resolved as election night euphoria gives...